Cidara Therapeutics Inc

NASDAQ:CDTX   3:08:04 PM EDT
0.63
0.00 (-0.16%)
Products

Cidara Therapeutics Announces FDA Acceptance For Priority Review Of New Drug Application For Rezafungin

Published: 09/20/2022 20:11 GMT
Cidara Therapeutics Inc (CDTX) - Cidara Therapeutics Announces FDA Acceptance for Priority Review of New Drug Application for Rezafungin for the Treatment of Candidemia and Invasive Candidiasis.